Denver Police Purchase MyClyns(TM) First Response Protection Spray in Advance of...

* Reuters is not responsible for the content in this press release.

Wed Aug 27, 2008 11:48am EDT

Denver Police Purchase MyClyns(TM) First Response Protection Spray in Advance
of the Democratic National Convention
Denver Police Department supplies officers with 1,000 units to provide
additional protection against possible pathogenic exposures as large crowds
are expected to gather in Denver

DENVER, Aug. 27 /PRNewswire/ -- Union Springs Pharmaceuticals, LLC,
announced today that the Denver Police Department has ordered 1,000 MyClyns
units in anticipation of the gathering of tens of thousands of people during
the Democratic National Convention being held August 25th through the 28th.
    MyClyns contains a fast-acting solution with germ-killing action that can
be safely sprayed directly into eyes, ears, nose, mouth, and open wounds.
MyClyns is currently being used throughout the U.S. by personnel in emergency
medical, police, fire, corrections, military, healthcare, and homeland
security. With its convenient pen-like design, MyClyns is a valuable tool that
enables first responders to protect themselves immediately after exposure to
potentially harmful pathogens. These pathogens are often contained in bodily
fluids such as blood or saliva.
    "We are pleased that MyClyns will be used to assist the Denver Police
Department and their officers," said Joel Ivers, President of Union Springs
Pharmaceuticals. "As the only personal protection spray that can be used
directly in the eyes, nose, and mouth, we are proud that MyClyns can play a
part in keeping officers safe."
    About MyClyns(TM)
    MyClyns(TM) (a pen-like device) is the only convenient, non-alcohol, first
response spray providing personal protection immediately after a potentially
pathogenic exposure.  MyClyns contains a fast-acting solution with
germ-killing action that is safe to use on all mucous membranes, including the
eyes, nose, ears, mouth and on open wounds.  Independent laboratory tests show
that the solution in MyClyns demonstrated a 99.99% reduction in HIV-1,
Hepatitis C, MRSA, C-diff and many other pathogens. MyClyns allows personnel
to protect themselves after a pathogenic exposure when complete post-exposure
protocols are rarely available.  Visit the MyClyns website at www.myclyns.com
for more information.
    About Union Springs Pharmaceuticals, LLC
    Union Springs Pharmaceuticals, LLC (USP) specializes in providing
innovative over-the-counter (OTC) products for the consumer and healthcare
markets. USP licenses, acquires, develops, and commercializes innovative
products and technologies that satisfy the unmet needs of healthcare
professionals and consumers. Union Springs Pharmaceuticals can be found on the
Internet at www.uspharma.com
SOURCE  Union Springs Pharmaceuticals, LLC

Bryan Reynolds, +1-859-384-4029 ext. 109, breynolds@uspharma.com, or Jim
Elliott, +1-859-384-4029 ext. 101, jelliott@uspharma.com, both of Union
Springs Pharmaceuticals, LLC
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.